Escherichia coli - Antibiogram Data

Inpatients (All Isolates)
% of Isolates Susceptible

Antibiogram

5.2% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram

5.2% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram

5.2% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram

5.2% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram

5.2% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram

5.2% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram

5.2% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram

5.2% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram

5.2% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram

5.2% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram

5.2% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram

5.2% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Antibiogram

5.2% of combined E.coli, K.pneumoniae, and P.mirabilis isolates were ESBL (extended spectrum beta-lactamase) positive

Note

  • January 1, 2018 - December 31, 2018

  • R: Intrinsically resistant or less than 25% empiric susceptibility